Upon recognition of TAAs presented by major histocompatibility complex class I (MHC-I) molecules on the tumor cell surface, CTLs are activated and exert their cytotoxic effects by releasing perforin and granzymes, which induce apoptosis in the target tumor cells [33]. The gene discussed is PRF1; the disease is neoplasm.